Syllabus demo

1.1.1.Sensory threshold, detections, modalities, adaptation and coding

1.1.2.Active and passive perception

1.1.3.Auditory, the vestibular sense, the skin senses, pain, smell, taste and visual sensations (including colour, contract and shape), interoception and proprioception

1.1.4.Visual pathway, dorsal and ventral systems, the binding problem, perceptual constancy, unconscious inference and illusions, the development of visual perception as an interaction between the intrinsic and extrinsic factors

1.1.5.Network models of perception, feature nets, features to geons to meaning, depth and motion, the role of redundancy of perception, figure ground differentiation, Gestalt theories

1.1.6.Information processing and attention, salience theory and the relevance of perceptual theory to hallucinations and other psychopathology

1.2.1.Neural correlates of consciousness, the global workspace hypothesis

1.2.2.Mind-body dichotomy, its fallacies and dual aspect monism

1.2.3.Sleep, sleep structure and dreaming, parasomnias, biorhythms, effects of sleep deprivation

1.2.4.Altered state of consciousness, spiritual, religious, drug induced, trance state, 'psychedelic' induced states and dissociative states

1.2.5.Consciousness, the cognitive unconscious, translating thoughts into words and critiques of the conscious unconscious divide

1.2.6.Mistaken introspections and identities, unconscious attributions

1.2.7.Brain damage and unconscious functioning, arousal, delirium

1.3.1.Neural basis for learning, how different species learn

1.3.2.Psychology of punishment and reward, emotional regulation and learning including threat, soothing and drive

1.3.3.Classical conditioning and the relationship between the conditioned and unconditioned reflexes

1.3.4.Thorndike and the law of effect, Skinner and operant behaviour

1.3.5.Generalisation of learning and habituation, chaining, shaping, cueing and the impact of various reinforcement schedules

1.3.6.Observational learning theory including Piaget, Vygotsky and Bruner

1.3.7.Changing behaviours or acquiring knowledge

1.3.8.Relation of learning processes to development of clinical problems

1.4.1.Acquisition, storage, consolidation, retrieval, constructive and reconstructive

1.4.2.Neural basis for memory including models of long-term potentiation

1.4.3.Sensory memories, working memory model, Baddeley's phonological loop and visuo-spatial scratch pad model

1.4.4.Short-term memory, long-term memory, establishing long-term memories

1.4.5.Hierarchy of memory types, episodic and semantic memory, subtypes of episodic memory, explicit and implicit (emotional and procedural) memory

1.4.6.Gaps in memory, distortion, inference, forgetting and memory intrusions, false memory, flashbulb memory, accuracy of eyewitness testimony, trauma and memory

1.4.7.Memory disorders and their assessment, and the relevance of memory and cognitive function in psychiatric disorders and their assessment

1.5.1.Intelligence as a construct, factor analysis and the idea of general intelligence

1.5.2.Intelligence testing, the psychometric approach, measuring intelligence and assessment tools, reliability and validity, cultural context and limitations

1.5.3.A hierarchical model of intelligence, fluid intelligence (gf) and crystallised intelligence (gc)

1.5.4.Mental speed, working memory and attention, executive control, other influences on intellectual functioning

1.5.5.Practical intelligence, emotional intelligence, the theory of multiple intelligences

1.5.6.The cultural context of intelligence

1.5.7.Problems with 'nature vs. nurture', genetics, epigenetics and individual IQ, environment and individual IQ, heritability ratios, group differences in IQ

1.6.1.Concepts, prototypes and cores, heuristics and dual process theory

1.6.2.Executive functions, high level such as initiation, planning and multi-tasking versus low level inhibition, cognitive flexibility and working memory judgment (Miyake model), deductive and inductive reasoning

1.6.3.Reasoning, cognitive bias such as recency and confirmation bias, logical fallacies, cognitive consistency and dissonance

1.6.4.Factors affecting decision making, including groupthink, cultural factors, human factors

1.6.5.Problem solving, hierarchical organisation, automaticity, obstacles to problem solving and overcoming obstacles to solutions

1.6.6.Theories of creativity including associative theory, interactionist theory and play

1.7.1.Sound units, morphemes and words, phrases and sentences

1.7.2.Language in nonhumans, the social origins of language learning

1.7.3.Language differences and development and impact on thought, experience and understanding

1.7.4.Development of language in infancy, language deprivation, language without sound, children deprived of access to some of the meanings, children exposed to more than one language, the case of bilingualism, the sensitive period hypothesis

1.7.5.How language connects to thought

1.7.6.Communicative competence, verbal, paraverbal and non-verbal communication

1.8.1.Motivational states, extrinsic and intrinsic stimuli

1.8.3.Cultural and cognitive aspect of threat and aggression, sexual behaviour, motivation, belonging and achievement

1.8.4.Maslow and the hierarchy of needs

1.8.5.Need for achievement (nAch)

1.9.1.Facets of emotion, cognitive appraisal, differentiation and the status of primary emotions

1.9.2.Functions of emotion, social communication, survival and motivation

1.9.3.Critical appraisal of James-Lange and Cannon-Bard theories

1.9.4.Stress, physiological and psychological aspects of stress response, the role of adrenaline and the parasympathetic nervous system, rating scales and physiological measurements

1.9.5.Situational factors, life events, daily hassles and uplifts, conflict and trauma, vulnerability and invulnerability, type A or B responses

1.9.6.Emotion regulation, adaptive, harmful coping mechanisms, locus of control, learned helpfulness, learned resourcefulness, resilience and burn out

1.11.1.Basic frameworks for conceptualising development, nature and nurture, stage theories, maturational tasks (Erikson) and possible definitions of maturity

1.11.2.Examination of gene-environment interactions with specific reference to intelligence, relative influence of early versus later adversities, the relevance of developmental framework for understanding the impact of specific adversities such as trauma

1.11.3.Methodology for studying development, cross sectional, cohort and individual studies, identification and evaluation of influences

1.11.4.Genetic and epigenetic influences on development including gene environment interactions

1.11.5.Neuroimaging and its role in understanding development and up to date findings in this field

1.12.1.Psychoanalytic theories of development

1.12.2.Attachment theories and relevance to emotional development, affect regulation and human relationships in childhood and later on, conditions for secure attachment, types and clinical relevance of insecure and disorganised attachment, early separation and its consequences, consequences of failure to develop selective attachments, maternal 'bonding', parental sensitivity, impact of deprivation and neglect with reference to relevant literature

1.12.3.Adverse childhood experiences (ACE), bereavement, parental divorce on subsequent development and mental health of the child and adult

1.12.4.Family relationships and parenting practices, the influence of parental attitudes compared with parenting practices, systemic theory including supportive systems in development, and aspects of distorted family function, discord, overprotection, rejection, and enmeshment, different family structures and cultural influences on family and stages of family

1.12.5.Factors affecting parent-child relationships, origins, typologies and stability of temperament and the evolution of character and personality, childhood vulnerability and resilience with respect to mental health

1.12.6.Development of social competence and relationships with peers, acceptance, group formation, co-operation, friendships, isolation and rejection and the components of popularity

1.12.7.Moral development with critical reference to Kohlberg's stage theory and relationship to development of social perspective taking

1.12.8.Development of emotion literacy and emotional regulation in childhood and adolescence including development of fears in childhood and adolescence with reference to age and possible aetiological and maintenance mechanisms

1.12.9.Sexual development, including the development of sexual identity and preferences, psychological, physiological, cultural and cognitive aspects of sexuality and sexual orientation

1.12.10.Adolescence as a developmental phase with special reference to pubertal changes, task mastery, conflict with parents and authority, affective stability and 'turmoil', normal and abnormal adolescent development, hormonal change and impact on mental state

1.12.11.Adaptations in adult life, such as pairing, parenting, illness, bereavement and loss

1.12.12.Pregnancy and childbirth and their stresses both physiological and psychological and embryological development

1.12.13.Development of personal (ego) identity in adolescence and adult life, work, ethnic, gender and other identities, mid-life 'crises'

1.12.14.Normal ageing and its impact on physical, social, cognitive and emotional aspects of individual functioning, impact of menopause, social changes accompanying old age, importance of loss, personality changes with ageing, social and economic factors in old age, attitude, status of the elderly, retirement, income, accommodation and socio-cultural differences

2.3.3.Animal models of psychiatric disease

2.3.4.In vitro models including iPSCs and organoids

2.3.5.Data analysis and computational modelling

2.4.1.Cells found within the nervous system and their anatomical and functional localisation in layers in different parts of the cortex

2.4.2.Fundamental concepts in the physiology of neurones, synapses and receptors, including an understanding of resting potential, action potential, ion fluxes and channels, G-protein coupled receptors, allosteric modulation of receptors, long-term potentiation, synaptic plasticity and pruning

2.4.3.Modelling single neurons and their combination in circuits

2.4.4.Glia

2.5.3.Neurochemistry of opioids and common recreational drugs

2.6.1.Anatomy of the brain and the functions of the lobes and some of the major gyri including the prefrontal cortex, cingulate gyrus, limbic system and knowledge of cranial nerve and spinal cord structure

2.6.2.Anatomy of the basal ganglia, caudate, putamen, globus pallidus, ventral striatum, substantia nigra and subthalamic nucleus

2.6.3.Internal anatomy of the temporal lobes, hippocampal formation and amygdala, neurogenesis and its possible role in mental health, temporal lobe epilepsy

2.6.4.Internal anatomy of the frontal lobes and cingulate gyrus

2.6.5.Major white matter pathways, corpus callosum, fornix and other pathways relevant to integrated behaviour

2.6.6.Ascending neurotransmitter systems including the nigrostriatal, mesolimbic and mesocortical dopamine pathways, the ascending noradrenergic pathway from the locus coeruleus, the basal forebrain cholinergic pathway, the brain stem cholinergic pathway, the corticofugal glutamate system and serotonin pathways

2.7.2.Brain networks and dysconnectivity including default mode, task focus and salience networks

2.8.1.Hypothalamic-pituitary (neuroendocrine) axis

2.8.2.Stress response and glucocorticoids

2.8.3.Hormonal changes and neuroendocrine changes in psychiatric disorders

2.8.4.Inflammation and immune responses

2.8.5.Auto-immune contributions to psychiatric illness

2.8.6.Obesity and metabolism, role in psychiatric disorders and effects of treatments

2.8.7.Neuro-endocrine hypothalamic-pituitary-gonadal (HPG) reproductive axis

2.9.1.Basic genetic principles, methodologies for identifying genes, basic concepts, chromosomes, cell division, gene structure, transcription and translation, structure of the human genome, patterns of inheritance, traditional techniques, family, twin and adoption studies, distinction between direct gene analysis and gene tracking, genetic markers, linkage studies, linkage disequilibrium and logarithm of the odds (LOD) scores, genome wide association studies, genetic variants, genetic influences on development including gene-environment interactions, the functions of microRNA and other mechanisms for RNA inhibition

2.9.2.Common genetic variation

2.9.3.Rare variation and structural variation, conditions associated with chromosome abnormalities, principal inherited conditions encountered in psychiatric practice and the genetic contribution to specific psychiatric disorders

2.9.4.Methods to identify genetic disorders and molecular phenotyping, techniques in molecular genetics, restriction enzymes, molecular cloning and gene probes, whole genome sequencing, gene expression, microarray and RNA sequencing, proteomics, metabolomics and molecular quantitative trait loci

2.9.5.Molecular and genetic heterogeneity, phenotype and genotype correspondence and endophenotypes and biotypes

2.9.6.Epigenetics, the types, causes and effects of epigenetic modification and the transmission of these changes through generations, epigenetic techniques, methylation, chromatin accessibility, histone modifications, transgenerational epigenetic inheritance and how drugs, psychotherapy and good and adverse experiences can modify epigenetics

2.9.7.Gene modification, gene editing and functional validation, clustered regularly interspaced short palindromic repeats (CRISPR) and massively parallel reporter assays (MPRA)

2.9.8.Genetic techniques for causal inference including mendelian randomisation

2.9.9.Clinical application of genetics in psychiatry, prenatal identification, genetic counselling, the organisation of clinical genetic services, DNA banks and polygenic risk scores

2.10.1.Brain structure development and function throughout the lifespan from the foetal stages onwards

2.10.2.Neurodevelopmental models of psychiatric disorders

2.10.3.Neurobiology of attachment and the effect of trauma

2.10.5.Intellectual and learning disability

2.10.6.Effects of injury at different ages on the brain and mental function, traumatic brain injury, inflammatory lesions, multiple sclerosis, and neoplastic lesions

2.11.1.Autism

2.11.2.ADHD

2.11.3.Drug use, addiction, tolerance, withdrawal, relapse

2.11.4.Anxiety disorders

2.11.5.PTSD

2.11.6.Obsessive compulsive and related disorders

2.11.7.Major depressive disorders

2.11.8.Bipolar affective disorders

2.11.9.Psychosis

2.11.10.Neurocognitive deficits in psychotic disorders

2.11.11.Self-harm and suicidality

2.11.12.Medically unexplained symptoms, including 'functional neurological disorder' (FND), somatic symptom disorder (SSD) and bodily distress disorder (BDD)

2.11.13.Delirium

2.11.14.Sleep disorders

2.11.15.Intellectual and learning disability including specific genetic syndromes

2.11.16.Eating disorders

2.11.17.Epilepsy and seizures

2.11.18.Personality disorders

2.11.19.Comorbidity and multimorbidity

2.11.20.Menstrual related disorders

2.12.1.Emerging pharmacotherapies including ketamine, psychedelics and neuroplastogens

2.12.2.Pharmacogenetics

2.12.3.Electroconvulsive therapy

2.12.4.Psychological therapies

2.12.5.Brain and vagal stimulation

2.13.1.Concepts in the pathophysiology of neurodegeneration, prodromal disease and mild cognitive impairment, preclinical stages, spectra, domains and dimensions of disease, reserve and resilience, environmental causes, comorbidity and dual pathology

2.13.2.Alzheimer's disease

2.13.3.Vascular dementia

2.13.4.Fronto-temporal dementias, primary progressive aphasia and posterior cortical atrophy

2.13.5.Lewy body diseases including Parkinson's disease, multiple system atrophy (MSA) and associated syndromes

2.13.6.Prion diseases

2.13.7.HIV and related brain disease

2.13.8.Chronic traumatic encephalopathy

2.13.9.Metabolic conditions causing dementia syndromes, Wilson's disease

2.13.10.Fronto-straital conditions such as motor neuron disease (MND) and amiotrophic lateral sclerosis (ALS)

3.1.1.Classification, major classes and intra-class groups

3.1.2.Placebo effect in general and in research

3.1.3.Compliance, adherence, concordance, relevance and methods of maximisation including medicine optimisation

3.1.4.Assessment methods for efficacy and tolerability and monitoring including investigations such as laboratory testing and clinical rating scales

3.1.6.Drug regulation, the purposes and processes of licensing, 'approved' versus 'offlabel' use, branded versus generic drugs

3.1.7.Principles of evidence-based prescribing, the 'risk-benefit' appraisal and personalisation

3.2.2.Kinetic changes across the life span in health and disease

3.2.3.Drug-drug interactions and medication through pharmacokinetics

3.2.5.Principles of pharmacogenomics and pharmacogenetics

3.2.6.Principles of therapeutic drug monitoring, limitations with psychotropics including lithium and clozapine

3.3.5.Teratogenicity, developmental abnormalities and complications associated with psychotropic drug use in pregnancy and breastfeeding

3.3.7.Putative neurochemical changes associated with physical treatments such as ECT, rTMS, vagal nerve stimulation

3.3.8.Commonly used herbal remedies of relevance to psychiatry

3.4.3.Monitoring of efficacy and tolerability

3.4.6.Controlled substances in the United Kingdom (UK), drugs used in management of addictions and modes of action and safety, tolerability

3.4.8.Adverse event reporting

3.4.9.Social and legal implications in prescribing

4.1.1.Fundamental concepts

4.1.2.Consciousness and its disorders

4.1.3.Disorders of memory and cognition

4.1.4.Disorders of perception and reality distortion

4.1.6.Disorders of self and body, including depersonalisation and derealisation

4.1.7.Disorders of language and speech

4.1.8.Disorders of affect and emotion

4.1.9.Disorders of movement, volition and execution

4.2.1.International Classification of Diseases (ICD) and Diagnostic and Statistical Manual of Mental Disorders (DSM) as related to psychiatric diagnostics

4.2.2.International Classification of Functioning, Disability and Health (ICF)

4.2.3.Special needs education

4.3.1.History taking

4.3.2.Examination of the mental state

4.3.4.Ability to assess biological, psychological and social factors in predisposition to and onset and maintenance of psychiatric disorders

4.3.7.Risk assessment and safety planning, understanding of the evidence base, principles including predictive values and principles of co-producing or mutually agreed safety plans

5.1.1.Application of multidisciplinary team approaches

5.1.2.Psychiatrist's role in treatment and coordination of the various treatment processes involved

5.1.3.Medical, psychological and social interventions and their relevance to the management of psychiatric disorders

5.3.1.Indications, benefits, risks and outcomes of ECT

5.3.2.Indications, benefits, risks and outcomes of DBS, rTMS and psychosurgery

5.3.3.Practical aspects of ECT, DBS, rTMS and psychosurgery

5.6.1.General principles of capacity and consent to treatment

5.6.2.Ethical issues including seclusion, confidentiality and the implications of 'duty to warn'

5.6.3.Human rights legislation as it effects patients, psychiatric practice, restrictions on liberty and aspects of human rights legislation

6.2.1.Assessment of common psychiatric disorders which present in the perinatal period, understanding changes in prevalence and increased risk of new presentation or relapse of psychosis, depression, anxiety and OCD in the postnatal period

6.2.2.Ability to adapt risk assessment to consider the perinatal context, including risks of neglect and harm to baby as well as risks to self

6.2.3.Management of psychiatric emergencies in the perinatal period

6.2.4.Prescribing in pregnancy and breastfeeding, safety profile of common psychiatric medications in the perinatal period, alterations in pharmacokinetics and dynamics during the perinatal period

6.2.5.Assessment and management of the impact of perinatal mental illness on bonding and attachment

6.2.6.Assessment and management of psychiatric symptoms and patterns of presentation related to the menstrual cycle and menopause. Includes relevant investigations and pharmacological, psychological and social management strategies

6.3.1.Psychiatric assessment and management of patients with physical illness

6.3.2.Advice to specialist medical services

6.3.3.Psychiatric consequences and aspects of brain disease, damage, stroke and dysfunction

6.3.4.Medically unexplained symptoms

6.3.5.End of life care and bereavement support

6.4.1.Self-harm, suicide, crisis presentations, and the assessment and management of acute and chronic risk

6.4.2.Theory and practice of crisis intervention and home treatment

6.4.3.Differential diagnosis in acute psychiatric emergencies

6.4.4.Treatment methods in emergency situations including the use of appropriate legislation

6.5.1.Non-organic sexual dysfunction, including lack or loss of sexual desire, lack of sexual enjoyment and failure of genital response

6.5.2.Gender incongruence

7.2.1.Multidisciplinary team working as it relates to an older population

7.2.2.Relationships with and provision by social services and voluntary care sector

7.2.3.Liaison with medical specialists

7.2.4.Roles and responsibilities of carers

7.4.1.Neurological disorders such as Parkinson's disease and Huntington's disease

7.4.2.Cerebrovascular disease and sensory impairment

7.4.3.Emotional reactions to illness and chronic ill-health

7.4.4.Secondary and reversible causes of cognitive impairment

8.1.1.Psychoanalytic theory, psychodynamic theory and contemporary practice

8.1.2.Impact of childhood, lifetime and intergenerational experiences of nurture, adversity, trauma and socio-cultural influences on shaping personality, attachment style, mental health and resilience

8.1.3.Development of collaborative therapeutic alliance, therapeutic relationship, therapeutic frame, containment, object relations, defences, transference-countertransference, supportive and exploratory techniques, interpretation, mourning and ending processes, working through and processes of psychic change and their application within psychotherapy and psychiatric practice

8.1.4.Role of exploratory psychodynamic approaches within a stepped care approach to psychological therapies, including for recovery from complex trauma

8.1.5.Principles of and indications for brief and long-term psychodynamic therapy or more intensive psychoanalytic approaches

8.1.6.Principles of adapted and integrative short and long-term therapeutic approaches, including dynamic interpersonal therapy (DIT), psychodynamic interpersonal therapy (PIT), mentalisation based therapy (MBT), transference focused therapy (TFP), cognitive analytic therapy (CAT), therapeutic communities (TCs), neuropsychoanalysis

8.1.7.Application of neuroscience including affective neuroscience, predictive processes and active inference to psychotherapeutic practice

8.2.3.Third wave developments, including mindfulness, compassion focused therapy (CFT), acceptance and commitment therapy (ACT)

8.2.4.Trauma focused work, including eye movement desensitisation and reprocessing (EMDR) for PTSD, models for complex PTSD, staged approaches addressing stabilisation, trauma processing and recovery

8.2.5.Principles of dialectical behaviour therapy (DBT)

8.3.1.General systems theory and models of family therapy including dynamic, structural, strategic, psychoeducation and behavioural

8.3.2.Core techniques, including communication training, reframing, genograms, role-playing, behavioural interventions and psychoeducation

8.4.1.Specific and non-specific effects in psychotherapy and psychotherapeutic psychiatry

8.4.2.Sequencing, frequency and duration of interventions

8.4.3.Outcome research, types and time course of outcome studies

8.4.4.Use of guidelines and research evidence

8.4.5.Patient involvement

8.4.6.Approaches to increasing patient access and choice

8.5.1.Small and large group dynamics, matrix, basic assumption and working groups, therapeutic factors, mirroring, resonance, scapegoating, anti-group

8.5.3.Principles of therapeutic communities and enabling environments

8.5.4.The unconscious in work dynamics within teams and organisationally, organisational defences, approaches to containment of anxiety in organisations, impact on patients and staff of structural factors, including service organisation, uses of language and organisational resilience

8.5.5.Application of therapeutic principles to service design and development

8.6.1.Narrative and dialogical approaches, including narrative therapy, open dialogue, psychoeducation, solution focused therapy, transference focused psychotherapy (TFP), structured clinical management (SCM), general psychiatric management (GPM), arts therapies, interpersonal therapy (IPT), sensorimotor therapy, ecotherapy and psychedelic assisted psychotherapy

8.6.2.Online, digital and technology-enabled therapies and the impact of technology and remote working on therapeutic alliance

8.7.1.Psychiatric presentations in different inpatient and community settings, across the life course, related to social and cultural difference, and the role of cognitive, behavioural, systemic, contextual, psychodynamic and relational factors

8.7.2.Therapeutic relationships, building a clinical relationship, continuity of care, transitions and endings

8.7.3.Theories of personality development, change and levels of personality organisation, in relation to diagnosis, service delivery including psychotherapeutic approaches in the treatment of personality disorder

8.7.4.Relationships between psychological processes and mental health symptoms, including processes of loss and mourning, adaptation and resilience

8.7.5.Psychological distress on bodily health including in eating disorders, bodily distress and medically unexplained symptoms

8.7.6.Psychological approaches to self-harm, suicidal ideation, suicide and violence, the impact of these events upon staff and family members and suitable approaches for support and reflective practice

8.7.7.Key psychological factors, including relational factors in building a biopsychosocial formulation as an intervention and basis for management planning and for engaging with uncertainty and complexity

8.7.8.Principles and applications of relational prescribing, working with polypharmacy and treatment resistance, the pharmacotherapeutic alliance, psychological and relational factors affecting whether and how to prescribe and deprescribe

8.7.9.Approaches to clinician self-care and development, reflective practice, Balint groups, consultation with teams, working with teams and organisations

8.7.10.Public health implications of psychotherapeutic practice

8.7.11.Impact of issues of power, socio-cultural factors, diversity, ethical and legal considerations

9.1.1.Effect of parental mental disorder at different child developmental stages

9.1.2.Household dysfunction and impact on child development and functioning

9.1.3.Cultural variations in aetiology and management

9.3.1.Multidisciplinary team working as it relates to children and young people

9.3.2.Relationships with and provision by social services and voluntary care sector

9.3.3.Liaison with medical specialists

9.4.1.Needs of developing children and how these evolve over time

9.4.2.Types of child abuse

9.4.3.Psychiatrist's role in safeguarding children

9.5.1.Psychiatric presentation of physical illness

9.5.2.Interaction between psychiatric disorder and physical illness

9.9.1.Indications and contra-indications for in-patient care

9.9.2.Self-harm, suicide, crisis presentations, and the assessment and management of acute and chronic risk

11.1.1.Crimes and offences committed by mentally disordered offenders and their psychiatric relevance, particularly homicide, infanticide, assault, criminal damage, sexual offences, arson, stalking and other crimes of violence

11.1.4.Effect of victimisation and vulnerability, including anxiety states, post-traumatic stress disorder, suggestibility, anger and aggressive behaviour

11.1.5.Equality legislation and reasonable adjustments

11.2.1.Psychiatrist's role in the assessment of mentally disordered offenders, during arrest, prior to conviction, prior to sentencing and post sentencing

11.2.2.Psychiatrist's role in assessing criminal responsibility and fitness to plead

11.2.3.Medicolegal defences including diminished responsibility, insanity and automatism

11.2.4.Options for diversion from custody at different stages of proceedings

11.2.5.Principles in providing evidence to the court both in written reports and oral evidence

11.3.1.Principles and therapeutic application of environmental, structural, procedural and relational security

11.3.2.Essential components of a forensic service, the specific patient needs and disabilities that can be assisted by such a service provision

11.3.3.Prevalence of psychiatric disorder in prison populations, suicide in prisoners and psychiatric treatment in prison settings

11.3.4.Risk assessment and management in forensic psychiatric, and the use of validated and recognised risk assessment tools including HCR-20, PCL-R

11.3.5.Managing mentally disordered offenders discharged into the community

12.1.1.Normalisation, related social theories and their influence on service development

12.1.2.Transition from institutional to an individualised, needs-led approach

12.2.1.Prevalence and incidence of intellectual disability in the general population

12.2.2.Prevalence and incidence of superadded behavioural, psychiatric and other impairments

12.2.3.Factors which may account for observed high rates of psychiatric or behavioural disorders

12.3.1.Biological causes, including genetic and environmental factors

12.3.2.Clinical characteristics of the more common genetic disorders causing intellectual disability

12.3.3.Influence of psychosocial factors on intellectual and emotional development, including concept of secondary handicap

12.4.1.Assessment and communication with people with intellectual disabilities

12.4.2.Presentation and diagnosis of psychiatric illness and behavioural disorder in people with intellectual disability, including the concept of diagnostic overshadowing

12.4.5.Application of a multidisciplinary team approach to the management of mental health problems in people with intellectual disability

12.4.6.Specific syndromes, genetic disorders and their association with psychiatric or behavioural disorders and behavioural phenotypes

12.4.7.Impact of intellectual disability on the family and the psychological consequences of having a child with an intellectual disability

13.1.1.Critically appraise different studies and know key issues and biases for different studies

13.1.2.Different sources and hierarchy of evidence

13.1.3.Difference between various electronic databases

13.1.4.Cataloguing of research for efficient retrieval

13.1.5.Formulating clinical questions using the patient exposure or intervention, comparison, outcome, time (PECO(t)) formula

13.1.6.Approaches for arguing a cause-and-effect relationship

13.1.7.Strategies for enabling the patient to make an informed decision

13.3.3.n of 1 trial

13.3.4.Critically appraise n of 1 trial

13.3.5.Pragmatic trial

13.3.6.Critically appraise pragmatic trial

13.3.8.Internal and external validity of trials

13.3.9.Clinical trials and their stages

13.4.1.Difference between primary, secondary and meta-analysis

13.4.2.Extraction of studies from electronic databases

13.4.3.Heterogeneity, publication bias, funnel plot, quality assessment, meta-analysis, pooled odds ratio and sensitivity analysis

13.4.4.Role and limitations of meta-analysis to improve power and robustness of research

13.4.5.Difference between fixed and random effect models

13.4.6.Network meta-analysis

13.4.7.Critically appraise systematic review and meta-analysis

13.5.1.Prevalence

13.5.2.Sensitivity

13.5.3.Specificity

13.5.4.Predictive values

13.5.5.Likelihood ratios and nomograms

13.5.6.Pre-test odds, post-test odds and probabilities

13.5.7.Receiver operating characteristic curve (ROC) and AUC

13.5.10.Critically appraise diagnostic studies

13.6.1.Cost minimisation analysis

13.6.2.Cost benefit analysis

13.6.3.Cost effectiveness analysis

13.6.4.Cost utility analysis

13.6.5.Cost consequence analysis

13.6.6.Incremental cost effectiveness ratio

13.6.8.Critically appraise various types of economic evaluation studies

13.6.9.'Sensitivity analysis' in the context of an economic evaluation

13.7.1.Qualitative research methodologies including grounded theory, phenomenological, ethnographic and other methodologies

13.7.2.Sampling techniques, including convenience sampling, purposive sampling, quota sampling, snowball sampling, chain referral sampling, theoretical sampling, data saturation and other techniques

13.7.3.Data collection techniques, including semi structured interviews, in depth interviews, focus group, observation, diary methods, ethnographic interviews, role play and simulation, case study, voice recordings and other techniques

13.7.6.Mixed methods

13.7.7.Critically appraise various qualitative studies

13.8.1.Difference between sample and population

13.8.2.Type of data including binary, nominal, ordinal, interval and ratio

13.8.3.Difference between ratio odds rates

13.8.4.Measures of central tendency including mean, median and mode

13.8.5.Measures of dispersion and their calculations, including variance, standard deviation, standard error, range and outliers

13.8.6.Variance, standard deviation, standard error of the mean and median interquartile range and their calculations

13.8.7.Interpret and explain confidence interval for mean and proportions

13.8.8.Advantage of confidence intervals over p-values

13.9.2.Establishing alpha level and p-values

13.9.3.Differences between parametric and non-parametric tests and examples

13.9.4.Tests of statistical significance, including parametric, non-parametric and binary tests, such as t-tests, ANOVA, ANCOVA, MANOVA, Wilcoxon signed rank test, Wilcoxon matched pairs signed test, Mann Whitney U test, Friedman test, Kruksal-Wallis ANOVA, Kolmogorov-Smirnov (K-S) test, post hoc significance tests, Fisher's exact test, chi-squared test, Mcnemar's test, Yates correction, one tailed test, two tailed test, tests for normality

13.9.5.Type I error, type II error, power calculation

13.10.1.Linear correlation

13.10.2.Pearson's correlation coefficient

13.10.3.Spearman's rank correlation coefficient

13.10.4.Kendall's correlation coefficient

13.10.5.Phi correlation coefficient

13.10.6.Point-biserial correlation

13.10.7.Phi coefficient

13.10.8.Partial correlation

13.10.9.Canonical correlation

13.10.10.Linear regression

13.10.11.Logistic regression

13.10.12.Multiple regression

13.10.13.Multilevel regression

13.10.14.Polynomial regression

13.10.15.Multivariate multiple regression

13.10.16.Non-linear regression

13.10.17.Quantile regression

13.10.18.Poisson regression

13.11.3.Service evaluation

13.11.4.Implications of clinical governance

13.12.2.Process for developing national guidelines, such as National Institute for Health and Care Excellence (NICE) and Scottish Intercollegiate Guidelines Network (SIGN) guidelines

13.12.3.Advantages and limitations of guidelines and protocols

13.13.1.Nodes (vertices)

13.13.2.Edges (links)

13.13.3.Network graph

13.13.4.Degree (connectivity)

13.13.5.Centrality measures

13.13.6.Clusters and communities

13.13.7.Paths

13.13.8.Network density

13.13.9.Network diameter

13.13.10.Network motifs

13.13.11.Network types

13.13.12.Subgraphs

13.13.13.Assortativity

13.13.14.Network visualisation

13.13.15.Connectivity and resilience

13.14.1.Good research practice

13.14.2.Research governance framework

13.14.3.Ethics approval for studies

13.14.4.Declarations of interest and funding

13.14.5.Research fraud